Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes (Q44126476)

30 November 2017

title

Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes (English)

1 reference

30 November 2017

Steven M Willi

1 reference

30 November 2017

Adele Kennedy

1 reference

30 November 2017

Bethany P Brant

1 reference

30 November 2017

Penny Wallace

1 reference

30 November 2017

Nikki L Rogers

1 reference

30 November 2017

W Timothy Garvey

1 reference

30 November 2017

publication date

1 November 2002

1 reference

Diabetes Research and Clinical Practice

30 November 2017

published in

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

87-96

1 reference

Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

The effects of cortisol on insulin sensitivity in muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Thiazolidinediones: a new class of antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Modified colorimetric ultramicro method for estimating Nefa in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Effects of troglitazone on dexamethasone-induced insulin resistance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Glucocorticoids and insulin resistance: old hormones, new targets

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Troglitazone action is independent of adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Free fatty acids, insulin resistance, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

The biology of leptin: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900127-4

7 January 2021

10.1016/S0168-8227(02)00127-4

Identifiers

DOI

1 reference

30 November 2017

1 reference